Filing Details
- Accession Number:
- 0001127602-18-000128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-02 16:21:54
- Reporting Period:
- 2017-12-29
- Accepted Time:
- 2018-01-02 16:21:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1672709 | Michel Vounatsos | Biogen Inc. 225 Binney St. Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-29 | 780 | $320.55 | 4,879 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
